M Del Rosso Selected Research

Raloxifene Hydrochloride (Evista)

1/2005

Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Del Rosso Research Topics

Disease

3	Neoplasms (Cancer) 01/2017 - 04/2005
3	Rheumatoid Arthritis 09/2006 - 01/2005
2	Systemic Scleroderma (Systemic Sclerosis) 10/2006 - 09/2005
1	Pathologic Neovascularization 01/2015
1	Pathologic Processes 01/2015
1	Breast Neoplasms (Breast Cancer) 04/2008
1	Osteoarthritis 09/2006
1	Necrosis 09/2006
1	Synovitis 10/2005
1	Prostatic Neoplasms (Prostate Cancer) 04/2005
1	Neoplasm Metastasis (Metastasis) 04/2005
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2001

Drug/Important Bio-Agent (IBA)

6	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2017 - 01/2001
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2017 - 01/2001
3	Urokinase Plasminogen Activator ReceptorsIBA 04/2008 - 04/2005
1	Peptide Hydrolases (Proteases)FDA Link 01/2015
1	G(M3) GangliosideIBA 07/2013
1	Artificial Membranes (Artificial Membrane)IBA 07/2013
1	LipidsIBA 07/2013
1	ChemokinesIBA 04/2008
1	CXCR4 Receptors (CXCR4 Receptor)IBA 04/2008
1	piascledineIBA 09/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2006
1	Interleukin-1beta (Interleukin 1 beta)IBA 09/2006
1	Tissue Inhibitor of Metalloproteinase-1IBA 09/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2006
1	Plasminogen InactivatorsIBA 10/2005
1	deflazacortIBA 10/2005
1	Alprostadil (Muse)FDA LinkGeneric 09/2005
1	Antisense OligonucleotidesIBA 04/2005
1	Raloxifene Hydrochloride (Evista)FDA Link 01/2005